“…In the present study, both ESBL and non-ESBL E. coli displayed nearly equivalent prevalence rates among patients receiving treatment in both the Intensive Care Unit (ICU) and non-ICU settings, constituting 67% of the total cases, as indicated in Figure 3. Although the prevalence of extended-spectrum beta-lactamase (ESBL)-producing E. coli is notably higher within Intensive Care Units (ICUs), it is important to acknowledge that non-ICU patients are also exposed to significant risks of colonization or infection, especially individuals residing in long-term care facilities (LTCFs) or those with a history of recurrent hospitalizations [8,22,23]. These non-ICU patients may exhibit similar risk factors as their ICU counterparts, including prolonged hospital stays and extensive antibiotic exposure [8,22,23].…”